Clinical Trial Update: Platform Clinical Study for Conquering Scleroderma [Phase 2]

View source ↗

Summary

Phase 2 platform clinical study to conquer systemic sclerosis (scleroderma) is currently recruiting, with a focus on interstitial lung disease due to systemic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Sclerosis

Snippet

Sponsor: Scleroderma Research Foundation, Inc. | Conditions: Interstitial Lung Disease Due to Systemic Disease, Scleroderma | Phase 2 | Status: RECRUITING